Rockefeller Neuroscience Institute

Last updated
Rockefeller Neuroscience Institute
Rockefeller Neuroscience Institute logo, April 2018.jpg
Rockefeller Neuroscience Institute
Geography
Location33 Medical Center Drive [1] , Morgantown, West Virginia, United States
Coordinates 39°39′12″N79°57′36″W / 39.653290°N 79.960080°W / 39.653290; -79.960080
Organization
Type Research
Affiliated university West Virginia University
History
Opened1999
Links
Website wvumedicine.org/rni
Lists Hospitals in West Virginia
Blanchette Rockefeller Neuroscience Institute BlanchetteRockefellerNeurosciencesInstitute.jpg
Blanchette Rockefeller Neuroscience Institute


The Rockefeller Neuroscience Institute is an independent, non-profit institution focused on the study of human memory and memory diseases. Founded in 1999, [2] the institute is part of the West Virginia University Medicine Health Sciences Campus, located in Morgantown, West Virginia. [3] [4] [5] The institute is one of the world's leading research centers focusing on innovative procedures to treat Alzheimer's disease and to expand clinical, research and academic missions of neurosurgery, neurology, behavioral medicine, psychiatry and other neuroscience issues. [6] [7] [8] [9] [10]

Contents

History

In 1999, United States Senator John Davison "Jay" Rockefeller IV and members of the Rockefeller family funded the formation of the Blanchette Rockefeller Neurosciences Institute on the campus of West Virginia University. The institute was named in honor of Blanchette Ferry Rockefeller, his late mother, who died in 1992 following a ten-year battle with Alzheimer's disease. [2] By 2001, the Rockefeller family had committed $15 million to the institute, which inspired many additional donors to support the facility and its efforts to accelerate discovery of treatments and cures for neurological and psychiatric diseases. [11] The $15 million gift was the founding endowment for the institute to establish the world's first major research institute focused on the prevention, diagnosis, treatment and cure of neurological, psychiatric, and other cognitive disorders affecting the human brain, with an emphasis on Alzheimer's disease. [12]

In 2016, the Blanchette Rockefeller Neurosciences Institute was acquired by and consolidated under West Virginia University and renamed Rockefeller Neuroscience Institute. [13] [14]

In 2018, the institute opened four state-of-the-art SMART neurosurgery operating rooms at its main campus to expand its capabilities in epilepsy surgery and deep brain stimulation. [15]

Leadership

In 2017, West Virginia University President E. Gordon Gee announced the appointment of board-certified neurosurgeon Ali Rezai to lead the Rockefeller Neuroscience Institute and oversee its efforts to develop solutions for neurological and psychiatric conditions. [16] [17] As executive chair of the Rockefeller Neuroscience Institute and the John D. Rockefeller IV Chair in neuroscience, Rezai is recognized as a pioneer [18] [19] [20] in neuromodulation technologies to treat Parkinson's disease, obsessive–compulsive disorder, Alzheimer's disease and traumatic brain injury. [16] [21] [22]

Rezai formerly served as director of Ohio State University's Wexner Medical Center's Neurological Institute, where he pioneered the use of neuromodulation technologies to treat Parkinson's disease, depression, obsessive– compulsive disorder and traumatic brain injury. [23]

Clinical trials

Alzheimer's

On October 16, 2018, a retired nurse diagnosed with Alzheimer's disease became the world's first person to undergo a Phase II clinical trial at the Rockefeller Neuroscience Institute of a new procedure using ultrasound waves to slow the effects of Alzheimer's. [24] [25] [26] The procedure, requiring no incisions into the brain, applied a new use of an ultrasound helmet, called Exablate Neuro, with 1,022 probes combined with magnetic resonance imaging (MRI) to deliver low-intensity ultrasound waves that converge to target the hippocampus. [27]

Chronic Pain & Opioid Use

On November 15, 2018, the Rockefeller Neuroscience Institute at West Virginia University became the first site in the nation to enroll a patient in a randomized Phase III clinical trial to reduce opioid use for chronic pain. [28] [29] [30] [31] [32] The patient was injected in the lower back with a non-opioid, non-steroid clonidine micropellet to treat sciatica pain for up to one year. The trial marked an effort to reduce opioid use in West Virginia and the nation for chronic pain. [31] [33] [34] Per capita, West Virginia has the highest number of opioid-addicted individuals. [35]

On November 1, 2019, the institute's Executive Chair Dr. Ali Rezai surgically implanted a deep brain stimulator chip into the nucleus accumbens part of the human brain to reduce human cravings for drugs, particularly opioids. [36] This marked the first time that deep brain stimulation was performed in the United States for drug addiction. West Virginia has the highest age-adjusted rate of drug overdose deaths involving opioids in the US, with a rate of 49.6 deaths per 100,000 persons in 2017, according to the National Institute on Drug Abuse. [37]

Sleep

In May 2018, the institute began a clinical trial on sleep cycles with Thrive Global, the wellness company founded by Arianna Huffington. [38]

Curriculum

In April 2019, the West Virginia University Board of Governors created a new Department of Neuroscience in its School of Medicine to consolidate neuroscience education in neurology, neurosurgery, behavioral medicine and psychiatry and advance research in brain health and brain disorders. [39]

Campus

The Rockefeller Neuroscience Institute is located on West Virginia University's Medicine Health Sciences Campus, in Morgantown, West Virginia. Construction of the institute began on May 1, 2006, at an initial cost of $30 million to build a state-of-the-art, four-story multidisciplinary laboratory space and administrative offices for 40 research scientists and 200 total employees. [40] The institute's 87,000 square foot building was designed by Shepley Bulfinch Richardson and Abbott of Boston, Massachusetts. [41] In 2019, a $25 million renovation was begun to expand the institute's research infrastructure. [15]

On April 23, 2019, the West Virginia University Rockefeller Neuroscience Institute announced the opening of its new Innovation Center that is a dedicated building focused on the use of advanced technology for rapid applied human research in neuromodulation, virtual reality and neuroscience predictive data analytics.

Related Research Articles

<span class="mw-page-title-main">Neurology</span> Medical specialty dealing with disorders of the nervous system

Neurology is the branch of medicine dealing with the diagnosis and treatment of all categories of conditions and disease involving the nervous system, which comprises the brain, the spinal cord and the peripheral nerves. Neurological practice relies heavily on the field of neuroscience, the scientific study of the nervous system.

<span class="mw-page-title-main">Jay Rockefeller</span> American politician (born 1937)

John Davison "Jay" Rockefeller IV is a retired American politician who served as a United States senator from West Virginia (1985–2015). He was first elected to the Senate in 1984, while in office as governor of West Virginia (1977–1985). Rockefeller moved to Emmons, West Virginia, to serve as a VISTA worker in 1964 and was first elected to public office as a member of the West Virginia House of Delegates (1966–1968). Rockefeller was later elected secretary of state of West Virginia (1968–1973) and was president of West Virginia Wesleyan College (1973–1975). He became the state's senior U.S. senator when the long-serving Senator Robert Byrd died in June 2010.

<span class="mw-page-title-main">CX717</span> Ampakine

CX717 is an ampakine compound created by Christopher Marrs and Gary Rogers in 1996 at Cortex Pharmaceuticals. It affects the neurotransmitter glutamate, with trials showing the drug improves cognitive functioning and memory.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

<span class="mw-page-title-main">National Brain Research Centre</span>

National Brain Research Centre is a research institute in Manesar, Gurugram, India. It is an autonomous institute under the Department of Biotechnology, Ministry of Science and Technology, Government of India. The institute is dedicated to research in neuroscience and brain functions in health and diseases using multidisciplinary approaches. This is the first autonomous institute by DBT to be awarded by the Ministry of Education, Government of India, formerly known as the Ministry of Human Resource Development, in May 2002. NBRC was dedicated to the nation by the Honorable President of India Dr. A.P.J. Abdul Kalam in December 2003. The founder chairman of NBRC Society is Prof. Prakash Narain Tandon, whereas the founder director Prof. Vijayalakshmi Ravindranath was followed by Prof. Subrata Sinha and Prof. Neeraj Jain. The current director of NBRC is Prof. Krishanu Ray.

Steven T. DeKosky is the Aerts-Cosper Professor of Alzheimer's Research at the University of Florida (UF) College of Medicine, deputy director of UF’s Evelyn F. and William L. McKnight Brain Institute (MBI) and associate director of the 1Florida Alzheimer’s Disease Research Center.

John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.

<span class="mw-page-title-main">Alzheimer's disease</span> Progressive neurodegenerative disease

Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation, mood swings, loss of motivation, self-neglect, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to twelve years.

Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She was the editor of the Annual Review of Neuroscience from 2018-2024.

<span class="mw-page-title-main">Neuroscience Research Australia</span>

Neuroscience Research Australia is an independent, not for profit medical research institute based in Sydney, Australia. The institute is made up of over 400 researchers specialising in research to improve the lives of people living with brain and nervous system disorders. The institute’s research spans neurodegeneration, including dementia and Parkinson’s disease; mental health and mental illness including bipolar disorder and schizophrenia; and translational neuroscience including falls prevention, pain and injury prevention.

<span class="mw-page-title-main">UCL Queen Square Institute of Neurology</span> Academic institution in United Kingdom

The UCL Queen Square Institute of Neurology is an institute within the Faculty of Brain Sciences of University College London (UCL) and is located in London, United Kingdom. Together with the National Hospital for Neurology and Neurosurgery, an adjacent facility with which it cooperates closely, the institute forms a major centre for teaching, training and research in neurology and allied clinical and basic neurosciences.

Clinical neuroscience is a branch of neuroscience that focuses on the scientific study of fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. It seeks to develop new ways of conceptualizing and diagnosing such disorders and ultimately of developing novel treatments.

The Mischer Neuroscience Institute is a combined research and education effort between the Vivian L. Smith Department of Neurosurgery and the Department of Neurology at McGovern Medical School at UTHealth Houston and Memorial Hermann Hospital. Located in Houston, the Institute draws patients from around the world for specialized treatment of diseases of the brain and spine. It was the first center in Texas and one of only a few institutions in the country to fully integrate neurology, neurosurgery, neuroradiology, neuro-oncology, spine surgery, pain medicine and neurorehabilitation.

Translational neuroscience is the field of study which applies neuroscience research to translate or develop into clinical applications and novel therapies for nervous system disorders. The field encompasses areas such as deep brain stimulation, brain machine interfaces, neurorehabilitation and the development of devices for the sensory nervous system such as the use of auditory implants, retinal implants, and electronic skins.

<span class="mw-page-title-main">Howard L. Weiner</span> American neurologist, neuroscientist and immunologist

Howard L. Weiner is an American neurologist, neuroscientist and immunologist who is also a writer and filmmaker. He performs clinical and basic research focused on multiple sclerosis (MS) and other neurologic diseases such as Alzheimer's disease and Lou Gehrig's disease (ALS). His work also focuses on autoimmune diseases such as diabetes. Weiner is the Robert L. Kroc Professor of Neurology at Harvard Medical School, director of the Brigham MS Center at the Brigham and Women's Hospital and co-director of the Ann Romney Center for Neurologic Diseases established in 2014, at the Brigham and Women's Hospital in Boston, Massachusetts.

<span class="mw-page-title-main">Giovanna Mallucci</span> British neuroscientist

Giovanna Rachele Mallucci is van Geest Professor of Clinical Neurosciences at the University of Cambridge in England and associate director of the UK Dementia Research Institute at the University of Cambridge. She is a specialist in neurodegenerative diseases.

Ali R. Rezai is an Iranian-born American neurosurgeon and neuroscientist. His work and research has focused on neuromodulation treatments for patients with neurological and mental health conditions, including neuromodulation techniques such as deep brain stimulation (DBS) through brain chip implants to treat Parkinson's disease tremors, obsessive–compulsive disorder, Alzheimer's disease, traumatic brain injury, spinal cord injury, and addiction. Recent research since 2020 has focused on deep brain stimulation for addiction treatment, as well as focused ultrasound to treat tremor, addiction and Alzheimer's disease.

<span class="mw-page-title-main">Clive Ballard</span> British researcher

Clive Ballard is a British, world-leading expert in dementia. He is currently Professor of Age-Related Diseases at the University of Exeter and Interim Deputy Pro-Vice-Chancellor and Dean of the University of Exeter Medical School.

<span class="mw-page-title-main">Andres M. Lozano</span>

Andres M. Lozano is a Spanish-Canadian neurosurgeon and scientist known for his work in Deep Brain Stimulation and MR guided Focused Ultrasound Surgery. He holds the Alan & Susan Hudson Cornerstone Chair in Neurosurgery at the University Health Network Toronto and is a University Professor at the University of Toronto. His work has been covered by major international news publications including BBC, Scientific American, The Independent, The Globe and Mail and NPR. He is also leading the exclusive Canadian site (CAN-PRIME) for the Neuralink trial.

References

  1. ↑ "Memory Health Clinic - Rockefeller Neuroscience Institute". 30 April 2020.
  2. 1 2 McCormick, Liz (29 May 2014). "Senator Rockefeller, Honored in Fight Against Alzheimer's". Wvpublic.org.
  3. ↑ Conor Griffith (28 March 2018). "WVU Medicine growing and recruiting to meet challenges". Wvnews.com.
  4. ↑ Wendy Holdren. "Researchers study how lighting impacts patient recovery". Beckley Register-Herald.
  5. ↑ "Pellet Carrying Blood Pressure Medication Offers New Hope For Sciatica Patients". February 21, 2019.
  6. ↑ "WVU's Rockefeller Neuroscience Institute leads breakthrough on Alzheimer's treatment". Wvnews.com. 2 November 2018.
  7. ↑ "Researchers succesfully[sic] open blood-brain barrier with focused ultrasound in Alzheimer's patient". Health Imaging. 29 October 2018.
  8. ↑ John Dahlia (28 October 2018). "Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer's". Wvnews.com.
  9. ↑ Matyola, Marisa (November 2, 2018). "WVU performs promising new Alzheimer's Therapy". WBOY.
  10. ↑ "Research Project Appears To Be Reversing Effects Of Alzheimer's". Philadelphia.cbslocal.com. February 27, 2019.
  11. ↑ "The Rockefeller Family and the Rockefeller Neuroscience Institute | WVU Rockefeller Neuroscience Institute". September 7, 2018. Archived from the original on September 7, 2018.
  12. ↑ "Blanchette Rockefeller Neurosciences Institute Receives $15 Million Gift". Philanthropy News Digest (PND). Retrieved 22 May 2019.
  13. ↑ "West Virginia University to acquire neuroscience facility". Apnews.com. August 2, 2016.
  14. ↑ "Neuroscience | School of Medicine | West Virginia University". Medicine.hsc.wvu.edu.
  15. 1 2 "Our Facilities and Future Growth". Wvumedicine.org. 15 February 2019. Retrieved 22 May 2019.
  16. 1 2 "WVU Forms New Neuroscience Institute". Bizjournals.com. Retrieved 22 May 2019.
  17. ↑ "Gordon Gee has REcruited 5 Execs from Ohio State". Bizjournals.com. Retrieved 22 May 2019.
  18. ↑ Baird, Gabriel (12 June 2009). "Dr. Ali Rezai, pioneering Cleveland Clinic neurosurgeon, taking Ohio State University post". Cleveland.com.
  19. ↑ "Ogio State Neurosurgeon Ali Rezai Leaving for West". Bizjournals.com. Retrieved 22 May 2019.
  20. ↑ "Photos Inside the Operating Room with Ohio States". Bizjournals.com. Retrieved 22 May 2019.
  21. ↑ "West Virginia University Rockefeller Neuroscience Institute Pioneers Promising New Alzheimer's Therapy". August 6, 2015.
  22. ↑ John Dahlia (January 2019). "Team responsible for Alzheimer's breakthrough is named NCWV Media 'West Virginian of the Year'". Wvnews.com.
  23. ↑ Murray, Brittany (24 November 2017). "New WVU Rockefeller Neurosciences Institute director brings plans for new research, clinical trials". Wajr.com. Retrieved 22 May 2019.
  24. ↑ Dahlia, John (28 October 2018). "Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer's". Wvnews.com. Retrieved 22 May 2019.
  25. ↑ "'Historic breakthrough Alzheimer patients around the globe have been awaiting'". HealthNewsReview.org. Retrieved 22 May 2019.
  26. ↑ "First procedure in trial for Alzheimer's treatment performed at WVU". Wdtv.com. 17 October 2018. Retrieved 22 May 2019.
  27. ↑ "Battling Alzheimer's through Better Access to the Brain". Blogs.scientificamerican.com. Retrieved 22 May 2019.
  28. ↑ "WVU tackles opioid crisis with clinical trial of injectable non-opioid micropellets to treat sciatica pain". January 7, 2019.
  29. ↑ "Experimental New Treatment Showing Promise For Those Who Suffer From Sciatica". February 19, 2019.
  30. ↑ Dahlia, John (18 November 2018). "WVU leading nation with potentially 'game changing' opioid addiction, Alzheimer's research". Wvnews.com.
  31. 1 2 Lori Kersey. "WVU researchers test non-opioid treatment for common back pain". Charleston Gazette-Mail .
  32. ↑ "West Virginia University first to launch clinical trial utilizing non-opioid micropellet". EurekAlert!.
  33. ↑ "Neuroscience Institute at WVU launches trial on implant for chronic pain". The Herald-Dispatch. 19 November 2018.
  34. ↑ "Pellet Carrying Blood Pressure Medication Offers New Hope For Sciatica Patients". Newyork.cbslocal.com. 21 February 2019. Retrieved 22 May 2019.
  35. ↑ "Can West Virginia Solve America's Healthcare Problems?". Fortune.com.
  36. ↑ "Deep brain stimulation is being tested to treat opioid addiction". The Washington Post. 2019-11-06. Retrieved 2022-02-18.
  37. ↑ "Man has chip placed in his head to help tackle opioid addiction". Independent.co.uk . 7 November 2019.
  38. ↑ "Can West Virginia Solve America's Healthcare Problems?". Fortune.com. Retrieved 22 May 2019.
  39. ↑ WVMetroNews (20 April 2018). "WVU Board of Governors approves creation of neuroscience department". WV MetroNews. Retrieved 22 May 2019.
  40. ↑ "WVUToday Archive". Wvutoday-archive.wvu.edu. Retrieved 22 May 2019.
  41. ↑ "West Virginia University to acquire neuroscience facility". Apnews.com. 2 August 2016. Retrieved 22 May 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.